Note: Ingredients listed on restricted chemical lists
EC/CAS
107534-96-3
Name of the chemical
1-(4-Chlorphenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (2015/1221)
Concentration
25% 25% 30% 20%
General Information
Revision date
2017-08-19
Product name
Tenazole 250 EW
Substance name
terbuconazole
CAS No.
107534-96-3
Icons in SDS
Company Information
company name
ARYSTA LifeScience South Africa (Pty) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@arysta.co.za
Section 2
Principle Routes of Exposure
Skin: Product is not harmful. However, the product is a skin irritant and may be corrosive due to emulsifiers. Not expected to be a skin sensitizer. Eye: The product is a severe irritant to the eyes. Lengthily exposure or delayed treatment may cause serious damage to the eyes. Inhalation: Not a hazard under normal use conditions. Prolonged or repeated exposure may irritate the nose, throat and respiratory tract. Regarded harmful. Swallowed: Data suggests the product is harmful if swallowed. Normal handling procedures is not expected to cause injury. If large amounts are swallowed and aspiration occurs, chemical pneumonitis may develop. Small amounts of product aspirated into the respiratory system during ingestion or vomiting, due to the solvent, xylene in the product, may cause mild to severe pulmonary injury. SECTION 4 - FIRST AID MEASURES AND PRECAUTIONS Inhalation: If vapours or mists have been inhaled, and irritation has developed, remove the source of contamination or move victim to fresh air. The patient should be kept under observation and obtain medical attention if irritation persists.
